Related Experiment Video
Updated: May 8, 2026
05:25
Extended 78% Hepatectomy in a Mouse Surgical Model
Published on: May 24, 2024
[Morbimortality in patients with hepatic trauma]
Olival Cirilo Lucena da Fonseca-Neto1, Rogério Ehrhardt, Antonio Lopes de Miranda
1Serviço de Cirurgia Geral e do Trauma do Hospital da Restauração – SUS, Recife, PE, Brasil. olivalneto@globo.com
Summary
Liver trauma is common in penetrating injuries, with a 10% mortality rate. Associated injuries and high Injury Severity Scores (ISS) significantly increase the risk of complications and death in hepatic trauma patients.
Area of Science:
- Trauma Surgery
- Surgical Outcomes
- Abdominal Trauma
Context:
- The liver is frequently injured in trauma patients, particularly in penetrating trauma cases.
- Hepatic trauma carries a significant mortality rate, necessitating evaluation of treatment and outcomes.
- Understanding injury patterns and patient factors is crucial for managing hepatic trauma.
Purpose:
- To evaluate mortality rates in patients with hepatic trauma.
- To analyze the applied treatments and their impact on patient outcomes.
- To identify factors associated with increased mortality and complications in hepatic trauma.
Summary:
- A retrospective analysis of 137 patients with surgically indicated hepatic trauma was conducted.
- The study examined demographics, injury characteristics (type, grade, segments involved), associated injuries, surgical interventions, complications, and mortality.
- Higher Injury Severity Scores (ISS > 50) and concomitant injuries to other organs were strongly associated with fatal outcomes and complications like biliary fistula and hepatic abscess.
Impact:
- Identifies critical injury severity score thresholds and associated injuries that predict poor outcomes in hepatic trauma.
- Provides data to inform surgical decision-making and resource allocation for managing severe liver injuries.
- Highlights the importance of comprehensive management strategies for patients with complex hepatic and associated injuries.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...